<DOC>
	<DOCNO>NCT01932476</DOCNO>
	<brief_summary>The purpose study determine whether immune response cause celiac disease relate autoimmune response cause type-1 diabetes .</brief_summary>
	<brief_title>Gluten Immunity Islet Autoimmunity Type-1 Diabetes</brief_title>
	<detailed_description>Participants meet eligibility criterion blood collect three-day oral gluten challenge . This blood test biomarkers associate islet autoimmunity gluten-specific cellular immunity .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<criteria>Diagnosis Celiac Disease histology serology For Type1 Diabetes , least one antiislet antibody HLADQ2.5 genotype Not follow gluten free diet least 12 month Known gluten exposure within prior 2 month Treatment systemic immune modify biological agent ( adalimumab , etanercept , infliximab , certolizumab pegol ) prior 6 month Treatment systemic immunomodulatory agent prior 30 day Human immunodeficiency virus infection , untreated hepatitis B virus , hepatitis C virus infection Nut allergy Hemoglobin level normal range History angina Pregnant lactating Severe symptom gluten challenge past Elevation transglutaminaseIgA deamidated gliadin peptide IgA IgG great equal 50 % upper limit normal Uncontrolled complication type1 diabetes celiac disease pose risk participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>